• Aucun résultat trouvé

Reimbursement of radiotherapy in Belgium

N/A
N/A
Protected

Academic year: 2021

Partager "Reimbursement of radiotherapy in Belgium"

Copied!
29
0
0

Texte intégral

(1)

Reimbursement of radiotherapy in

Belgium

The old reimbursement system

The new system

The desired system

Nicolas Jansen

(2)

Introduction

Belgium ≠ The Netherlands

Flanders = Wallonia

4 time periods

1. Historical situation

2. Activity based reimbursement system (2001-2012)

(minor modifications 2003)

3. The new quality stimulating reimbursement system (2013-…) 4. A new FINANCING based on needs and quality (202x-...)

(3)

Time period 2 : now

Gifts, sponsoring

Supplements paid by patients privately or by private insurance Reimbursed individual medical acts

To cover the complete running of the department (medical and paramedical wages,

goods, physics, medical immobile material, accelerators, …)

Financing of machines and staff on a department level

(4)

Time period 2 : now

Reimbursed individual medical acts

Financing of machines and staff on a department level

Supplements only possible for certain patients.

(5)

Time period 2 : now

Reimbursed individual medical acts

Financing of machines and staff on a department level

60% is paid by the federal government

(6)

Time period 2 : now

Reimbursed individual medical acts

Financing of machines and staff on a department level

We need an increase of >10%

A linear reduction of 1-2% was imposed in 2012

(7)

Time period 2 : now

Reimbursed individual medical acts

Financing of machines and staff on a department level

(8)

Reimbursement evolution

2002 2003 2004 2005 2006 2007 2008 2009 2010

(9)

Time period 3a : near future

Reimbursed individual medical acts

Financing of machines and staff on a department level

(10)

Time period 3b : future

Reimbursed individual medical acts

Financing of machines and staff on a department level

(11)

Time period 4 : needs to be defended

Reimbursed individual medical acts

Financing of machines and staff on a department level

based on a national analysis of needs

and the expected evolution of the patient population

If a good reimbursement is available for a given treatment,

‘everyone’ will start offering this treatment whether there is

a real need in a given area or not.

(12)

Time period 3a : ongoing negotiations

Reimbursed individual medical acts

Financing of machines and staff on a department level

(13)

Controversy

• How to get from time period 2 to time

period 4 ?

– Extremely gradually, through negotiations,

via step 3 (approach of the VBS/GBS at

this moment)

– Jump to step 4 directly, by a strong political

will to do so, after strong lobying (approach

favoured by the new radiotherapy platform)

(14)

What is the GBS/VBS

• « Verbond der Belgische Specialisten »

– Official representation of medical

specialists for discussions with the

government

– There is a global group (for all specialists)

– And there is a specific group for radiation

oncologists

≠ BVRO : scientific organisation

(15)

TREATMENT PREPARATION  

personalised immobilisation 125 125

simulation 300 300

second simulation 150 150

image fusion (simple, 2 techniques) NA 75

image fusion (complex, > 2 techniques) NA 150

delineation NA 250 2D+-planning / calculation ME 250 150 3D-planning (standaard) 250 + 125 375 3D-planning (intensive) 250 + 125 + 125 + 100 600 4D radiotherapy preparation NA 250 adaptive radiotherapy NA 150 individual shielding 75 or 150 100

TREATMENT EXECUTION AND QUALITY MEASURES    

Category 1 (extern simple) 500 500

Category 2 (extern complex standard fractionation) 1600 or 2000 2000

Category 3 (extern complex hypofractionation) 1200 or 1600 1500

Category 4 (extern complex stereotactic treatment) 2000 2000

image guidance at start 100 100

image guidance (correction protocol / start and weekly control) 100 500

image guidance online daily and intensive 100 1000

4D radiotherapy delivery NA 300

patient individual QA NA (100) 200

in vivo 100 100

existing, original price existing, lower price new

(16)
(17)

Place of brachytherapy

Reimbursed individual medical acts

Financing of machines and staff on a department level

(18)

Place of brachytherapy : period 2

(19)

Brachy cost versus external

• Percentage of total cost of the basic brachy procedures in a given year versus the costs of the total cost of the external beam treatments in the same year • Reduction is based on decrease in number of patients treated

2002 2003 2004 2005 2006 2007 2008 2009 2010

4,9

5,6

6,7

7,2

6,4

6,1

5,5

5,6

5,0

(20)

Brachy cost total

• All reimbursed acts (including

simulation, planning, afterloader, …)

• Not seeds, no hospital stay costs

• 3.900.000 euro in 2011

(21)

Place of brachytherapy : period 3

Reimbursed individual medical acts

(22)

Brachytherapy : present situation

• 2 ‘complexity levels’

• For each complexity level 2 situations :

– After an external beam radiotherapy (boost)

– Brachytherapy alone

(23)

Brachytherapy : present situation

• Problems

– Complexity levels are organ based

– Brachytherapy is reimbursed less if given as a boost, even is

the time and efforts invested are more or less the same

• First bad news for prostate brachytherapy by

permanent seed implants :

– no more

simulation

(2011) : minus K300

– Price of seeds is government controlled at 47,7 € /seed,

including transport and all other material used during the

procedure. Max 100 seeds/patient (2012)

(24)

Brachytherapy : future situation 3a

– 3

complexity levels

• Not image based (cheloids, …)

• Simple image based (geometrical, or CT/ultrasound)

• Idem, full 3D plan with multiple OAR and TV delineated

– Equal reimbursement as boost or not

– Quality stimulating measures of external

radiotherapy are also valid for brachytherapy

• Delineating

• Image fusion

• In vivo dosimetry

• …

(25)
(26)

   

Compulsory

 activity

   

Compulsory activity, but only one of these activities 

within the frame (and one per treatment)

   

Accepted

 activity

   

Accepted activity, but only one of these activities 

within the frame (and one per treatment)

   

Forbidden

 activity

(27)

 ONLY BRACHYTHERAPY AMOUNTS IN ‘K’, not euro

rubriek 0 No treatment delivered   rubriek 5 Simple brachytherapy rubriek 6 Standard brachytherapy rubriek 7 Complex brachytherapy   rubriek 8 kilovolt A. Treatment execution    500 1000 1250   B. Treatment preparation               First simulation        300 300     Second simulation              

Simple image fusion        75  

Complex image fusion       150   

Delineation        250  250     Simple planning      150       Standard planning      375     Complex planning        600   4D planning           Adaptive planning                         C. Quality/safety measures               Afterloading      100 (400) 100 (400) 100 (400)     Fixation system    125 125 125   Protective systems               IGRT (once)              

IGRT (standard protocol)          

IGRT (daily, online)          

4D treatment execution              

Patient specific phantom dosimetry          

In vivo dosimetry    100 100 100  

(28)

• Conclusion for the BELGIAN

reimbursement system

– Present reimbursement is not adapted to needs

– New reimbursement system …

• is not guaranteed at all

• does include quality stimulating measures

• is not a major change

• respects brachytherapy reimbursements

– No existing plans for a reimbursement system

based on objective needs and quality

Références

Documents relatifs

• Research attention focuses on barriers to diffusion of imported medical devices, and on how industry in developed countries can (re)design instruments for the developing world

So, the personalized approach to the processing of medical information is characterized by a number of problems, namely: the uncertainty of the data presented, the classifica- tion

L’annonce d’une exposition passée à un cancérogène comme l’amiante peut avoir des conséquences psychologiques défavorables en termes d’anxiété, alors même que la

The survey was administered after the residents had complete the first year of their family medicine residency and asked for the residents’ opinions about the value of EMRs,

Aside from the minority who have out-of-country group coverage from work or from another third-party policy, Canadians must purchase supplementary medi- cal insurance when

Its aim was to test the feasibility and utility of creating an ambulatory care research tool at individual beneficiary lev- el by linking medical data provided by an existing

Proposed changes include: alignment of medical device reimbursement with that of pharmaceuticals; relaxing the strict reimbursement criteria for ultra-orphan drugs; establishment of

Abstract We assessed the frequency of carriers of methicillin- resistant Staphylococcus aureus (MRSA) among 500 dental patients of a university clinic.. From each participant,